XML 42 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Assets:    
Cash $ 58,649 $ 20,096
Restricted cash 30,127 30,127
Securities available-for-sale, at estimated fair value 17,919 33,362
Securities, at estimated fair value 499,701 158,086
Investment in unconsolidated joint venture 38,719 0
Derivative instrument 1,933 0
Interest receivable 17,072 6,022
Deferred financing costs, net 8,124 628
Other assets 1,342 600
Total Assets 1,783,012 907,504
Liabilities:    
Borrowings under repurchase agreements 537,766 202,033
Convertible senior notes, net 246,054 0
Participations sold 89,418 0
Investments purchased, not yet settled 26,540 0
Accounts payable and accrued expenses 3,602 2,660
Payable to related party 3,193 2,628
Dividends payable 20,753 17,227
Total Liabilities 927,326 224,548
Commitments and Contingencies (see Note 16)      
Stockholders’ Equity:    
Preferred stock, $0.01 par value, 50,000,000 shares authorized, 3,450,000 shares issued and outstanding ($86,250 aggregate liquidation preference) 35 35
Common stock, $0.01 par value, 450,000,000 shares authorized, 46,848,675 and 36,888,467 shares issued and outstanding, respectively 468 369
Additional paid-in-capital 867,598 697,610
Retained earnings (accumulated deficit) (11,661) (14,188)
Accumulated other comprehensive loss (754) (870)
Total Stockholders’ Equity 855,686 682,956
Total Liabilities and Stockholders’ Equity 1,783,012 907,504
Commercial mortgage loans [Member]
    
Assets:    
Loans, held for investment 369,924 161,099
Subordinate loans [Member]
    
Assets:    
Loans, held for investment $ 585,504 $ 497,484